This disclosure describes recombinant cells and methods for microbial biosynthesis of ent-atiserenoic acid. Thus, in one aspect, this disclosure describes a recombinant cell genetically modified to exhibit increased biosynthesis of ent-atiserenoic acid compared to a comparable control cell. In some cases, the recombinant cell can include a host cell modified to include at least one heterologous polynucleotide encoding at least one enzyme in a biosynthetic pathway that produces ent-atiserenoic acid. In some cases, the recombinant cell can include a host cell and at least one heterologous enzyme in a biosynthetic pathway that produces ent-atiserenoic acid.
本公开描述了用于ent-atiserenoic acid 微
生物生物合成的
重组细胞和方法。因此,在一个方面,本公开描述了一种经过
基因修饰的
重组细胞,与可比对照细胞相比,该细胞的ent-atiserenoic acid
生物合成能力增强。在某些情况下,
重组细胞可包括经修饰的宿主细胞,该宿主细胞包括至少一种异源多核苷酸,该多核苷酸编码产生ent-atiserenoic acid的
生物合成途径中的至少一种酶。在某些情况下,
重组细胞可包括宿主细胞和产生ent-atiserenoic acid的
生物合成途径中的至少一种异源酶。